000 01430 a2200373 4500
005 20250516040827.0
264 0 _c20111208
008 201112s 0 0 eng d
022 _a1745-655X
024 7 _a10.1057/jphp.2011.34
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGuan, Xiaodong
245 0 0 _aAn analysis of China's national essential medicines policy.
_h[electronic resource]
260 _bJournal of public health policy
_cAug 2011
300 _a305-19 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aChina
650 0 4 _aDrug Industry
_xorganization & administration
650 0 4 _aDrug and Narcotic Control
_xlegislation & jurisprudence
650 0 4 _aDrugs, Essential
_xsupply & distribution
650 0 4 _aHealth Care Reform
_xlegislation & jurisprudence
650 0 4 _aHealth Policy
650 0 4 _aHealth Services Accessibility
_xorganization & administration
650 0 4 _aHumans
650 0 4 _aInsurance, Health, Reimbursement
650 0 4 _aNational Health Programs
_xlegislation & jurisprudence
650 0 4 _aPractice Patterns, Physicians'
650 0 4 _aQuality of Health Care
_xorganization & administration
700 1 _aLiang, Huigang
700 1 _aXue, Yajiong
700 1 _aShi, Luwen
773 0 _tJournal of public health policy
_gvol. 32
_gno. 3
_gp. 305-19
856 4 0 _uhttps://doi.org/10.1057/jphp.2011.34
_zAvailable from publisher's website
999 _c20874795
_d20874795